Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Risedronic Acid + Calcium Ion + Vitamin D3

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 73088858

  Document Type - Tender Notices

Description - Section 130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. GWQ acts as a company for efficiency an d quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGBV for its shareholders and customer funds. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until new drug discount agreements come into force, the GWQ would like to conclude dru

Mt Ref Id - 73088858

Deadline - Nov 10, 2024